On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Martha Mayo

ResearcherPublications, citations & collaboration network

Martha Mayo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Martha Mayo have?

ScholarIQindexed works

Martha Mayo has 67 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Martha Mayo have?

ScholarIQcitation count

Martha Mayo has 4,076 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Martha Mayo?

ScholarIQh-index

Martha Mayo has an h-index of 22 in OpenAlex.

What is the i10-index of Martha Mayo?

ScholarIQi10-index

Martha Mayo has an i10-index of 29 in OpenAlex.

What is the OpenAlex record for Martha Mayo?

ScholarIQopenalex

The OpenAlex for Martha Mayo is on the source record.

What are the most-cited papers on Martha Mayo?

ScholarIQmost cited works
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Matthew R. Weir, George L. Bakris, David A. Bushinsky, Martha Mayo, Dahlia Garza, Yuri Stasiv, Janet Wittes, Heidi Christ‐Schmidt, Lance Berman, Bertram Pitt
New England Journal of Medicine. 2014668 CitationsOPEN ACCESS
Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS
Peter S. Staats, Thomas Yearwood, Steven G. Charapata, R. Presley, Mark S. Wallace, Michael G. Byas‐Smith, Robert B. Fisher, David A. Bryce, Eugene A. Mangieri, Robert R. Luther, Martha Mayo, Dawn McGuire, David Ellis
JAMA. 2004646 Citations
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
George L. Bakris, Bertram Pitt, Matthew R. Weir, Mason W. Freeman, Martha Mayo, Dahlia Garza, Yuri Stasiv, Rezi Zawadzki, Lance Berman, David A. Bushinsky
JAMA. 2015440 Citations
Alzheimer's disease, normal‐pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis
Gerald D. Silverberg, Martha Mayo, Thomas Saul, Edward Rubenstein, Dawn McGuire
The Lancet Neurology. 2003433 Citations
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Rajiv Agarwal, Patrick Rossignol, Alain Romero, Dahlia Garza, Martha Mayo, Suzette Warren, Jia Ma, William B. White, Bryan Williams
The Lancet. 2019371 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial